13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000950123-25-008312
Total Value
$799.3M
Positions
23
Other Managers
12
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,719,110 | $194.1M | 24.29% |
| 2 | CIDARA THERAPEUTICS INC | 171757206 | 2,500,680 | $121.8M | 15.24% |
| 3 | NUVALENT INC | NUVL | 1,447,267 | $110.4M | 13.82% |
| 4 | PHARVARIS N V | PHVS | 3,303,381 | $58.1M | 7.27% |
| 5 | DIANTHUS THERAPEUTICS INC | DNTH | 2,482,250 | $46.2M | 5.79% |
| 6 | SAVARA INC | SVRA | 17,600,621 | $40.1M | 5.02% |
| 7 | SOLID BIOSCIENCES INC | SLDB | 7,911,669 | $38.5M | 4.82% |
| 8 | DISC MEDICINE INC | IRON | 583,500 | $30.9M | 3.87% |
| 9 | OLEMA PHARMACEUTICALS INC | OLMA | 6,843,954 | $29.2M | 3.65% |
| 10 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $29.1M | 3.64% |
| 11 | UPSTREAM BIO INC | UPB | 2,439,538 | $26.8M | 3.35% |
| 12 | CABALETTA BIO INC | CABA | 9,677,125 | $14.7M | 1.84% |
| 13 | TANGO THERAPEUTICS INC | TNGX | 2,712,008 | $13.9M | 1.74% |
| 14 | ANNEXON INC | ANNX | 5,249,069 | $12.6M | 1.58% |
| 15 | KYVERNA THERAPEUTICS INC | KYTX | 3,368,370 | $10.3M | 1.29% |
| 16 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $8.9M | 1.12% |
| 17 | XILIO THERAPEUTICS INC | XLO | 4,566,817 | $3.1M | 0.39% |
| 18 | CENTURY THERAPEUTICS INC | IPSC | 5,410,361 | $3.0M | 0.38% |
| 19 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $2.6M | 0.32% |
| 20 | C4 THERAPEUTICS INC | CCCC | 1,111,910 | $1.6M | 0.20% |
| 21 | INVIVYD INC | IVVD | 1,799,595 | $1.3M | 0.16% |
| 22 | X4 PHARMACEUTICALS INC | XFOR | 563,859 | $1.1M | 0.13% |
| 23 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $800,000 | 0.10% |